Request a FREE Sample of our FcRn Binding Kit!
Request a FREE Sample of our FcRn Binding Kit!
Limited Edition Golden Llama is here! Check out how you can get one.
Limited Edition Golden Llama is here! Check out how you can get one.
Request a FREE sample of our GMP products!
Request a FREE sample of our GMP products!
Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
COS-H52H3 | Human | Human Complement C1s Protein, His Tag | ![]() |
![]() ![]() |
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Conestat alfa | rhC1-INH | Approved | Pharming Group Nv | Rhucin, Esterasine, Ruconest | EU | Angioedemas, Hereditary | Pharming Group Nv | 2010-10-28 | Rejection of renal transplantation; Myocardial Infarction; Renal Insufficiency; Rejection of organ transplantation; Genetic Diseases, Inborn; Coronavirus Infections; Non-ST Elevated Myocardial Infarction; Angioedema; Angioedemas, Hereditary | Details |
Sutimlimab | BIVV-009; TNT-009 | Approved | True North Therapeutics | ENJAYMO | United States | Anemia, Hemolytic, Autoimmune | Bioverativ Therapeutics Inc | 2022-02-04 | Hemolysis; Purpura, Thrombocytopenic, Idiopathic; Anemia, Hemolytic, Autoimmune; Pemphigoid, Bullous; Kidney Failure, Chronic | Details |
Complement C1 inhibitor protein (Shire ViroPharma) | C1 INH-nf; C1-INH; SHP-616 | Approved | Sanquin Plasma Products Bv | Cinryze, Cetor | United States | Angioedemas, Hereditary | null | 2008-10-10 | Brain Injuries, Traumatic; Rejection of organ transplantation; Angioedemas, Hereditary | Details |
C1 esterase inhibitor (Human, CSL Behring) | BI-3.012; CSL-830; CSL-842; CE-1145 | Approved | Csl Behring Llc | Berinert, Haegarda, Berinert 2000 | Japan | Angioedemas, Hereditary | Csl Behring Llc | 1990-06-29 | Hereditary Angioedema Types I and II; Angioedemas, Hereditary | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Riliprubart | SAR-445088; TNT-020; BIVV-020 | Phase 3 Clinical | True North Therapeutics | Purpura, Thrombocytopenic, Idiopathic; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Polyneuropathies; Rejection of organ transplantation; Anemia, Hemolytic | Details |
C1 esterase inhibitor (Boya Bio-Pharmaceutical) | Phase 3 Clinical | Boya Bio-Pharmaceutical Group Co Ltd | Angioedemas, Hereditary | Details | |
Complement-C1 inhibitor protein (Octapharma) | Phase 2 Clinical | Octapharma | Angioedemas, Hereditary | Details | |
DNTH-103 | DNTH-103; DNTH103 | Phase 2 Clinical | Dianthus Therapeutics Inc | Myasthenia Gravis; Autoimmune Diseases | Details |
C1 esterase inhibitor (Chengdu Institute of Biological Products) | Phase 1 Clinical | Chengdu Institute Of Biological Products Co Ltd | Angioedemas, Hereditary | Details |
This web search service is supported by Google Inc.